CorMedix (CRMD) Tops Q1 EPS by 1c

CorMedix (NASDAQ: CRMD) reported Q1 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Starwood Property Trust (STWD) Reiterated at Market Outperform by Citizens
• NRC Health (NRC) Reiterated at Market Outperform by Citizens Ahead of Annual Forum